visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Royalty Pharma

    Get Full Access

    Description

    • Royalty Pharma is the industry leader in acquiring revenue-producing intellectual property principally royalty interests in marketed and late stage biopharmaceutical products with $15 billion in assets. Since inception in 1996, Royalty Pharma and its predecessors have invested approximately $11 billion to assemble a leading portfolio of Royalty Interests in pharmaceutical and biopharmaceutical products. Royalty Pharmas strategy has been to acquire Royalty Interests in leading pharmaceutical and biotechnology products and hold these interests as part of a portfolio, seeking to diversify its revenue base across product and therapeutic classes. Royalty Pharma captures many of the strong and predictable aspects of the pharmaceutical industy while limiting the typical risks of biopharmaceutical companies. Royalty Pharma currently owns a diversified portfolio of royalty interests in several high-quality blockbuster biopharmaceutical products, including Abbotts Humira®, J&J/Mercks Remicade®, Pfizers Lyrica®, Gileads Emtriva®, Truvada®, Atripla® and Striblid®, Biogen's Tecfidera®, Merck & Co.'s Januvia® and Janumet®, AbbVie's Imbruvica® and Vertex' Kalydeco® and Orkambi®.Royalty Pharma - funding scientific achievement since 1996.
    • location

      Headquarters:110 East 59th Street , New York, New York, United States

      More
    • Royalty Pharma phone

      Phone Number: +1 212-883-0200

    • Royalty Pharma website

      Website: https://www.royaltypharma.com

    • Royalty Pharma employees

      Employees:43

    • Royalty Pharma revenue

      Revenue:$50 - 100M

    • Royalty Pharma legal name

      Legal Name:Royalty Pharma

    • Royalty Pharma's Social Media

      Royalty Pharma linkedin
    • done Is this data correct?

    • |  NAICS Code: 325412  |

      Show More
    Person level website identification

    CEO for Royalty Pharma

    Pablo Legorreta

    Founder And Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Jim Reddoch

    Chief Scientific Officer Executive Vice President, Research And Investments

    Terrance Coyne

    Chief Financial Officer

    Kristin Stafford

    Senior Vice President, Chief Accounting Officer

    Chris Hite

    Executive Vice President And Vice Chairman

    Yoon Choo

    Vice President, Investments And Deputy General Counsel

    Frequently Asked Questions regarding Royalty Pharma

    • Where are Royalty Pharma's Headquarters?

      Royalty Pharma's Headquarters are in 110 East 59th Street ,New York,New York,United States

    • What is Royalty Pharma's phone number?

      Royalty Pharma's phone number is +1 212-883-0200

    • What is Royalty Pharma's official website?

      Royalty Pharma's official website is https://www.royaltypharma.com

    • What is Royalty Pharma's Revenue?

      Royalty Pharma's revenue is $50 - 100M

    • What is Royalty Pharma's NAICS code?

      Royalty Pharma's NAICS code is 325412

    • How many employees are working in Royalty Pharma

      Royalty Pharma has 43 employees

    • What is Royalty Pharma's Industry?

      Royalty Pharma is in the industry of Biotechnology

    • Who is Royalty Pharma's CEO?

      Royalty Pharma's CEO is Pablo Legorreta

    Company Directory